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Case report: JC virus induced Longitudinally Extensive Transverse Myelitis in
immunocompromised patient
Ghada A Mohamed MD, Gamal el Din Osman MD, Hassan Abd el Nour MD, Daniel Neuman MD, Angelos Katramados MD
Department of Neurology, Henry Ford Hospital, Detroit, Michigan

Introduction

Case Report Cont.

• John Cunningham virus (JCV) is a human polyomavirus that causes a fatal
demyelinating disease of the central nervous system (CNS) called progressive
multifocal leukoencephalopathy (PML).

His symptoms started with left lower extremity flaccid weakness and prominent
fasciculations that rapidly extended to involve the right leg. Shortly thereafter, he
developed urinary and fecal incontinence. His work up showed elevated CSF
protein at 90 gm/dl, negative bacterial growth, HSV 1 and 2, VZV, CMV, and
West Nile viral PCR, IgG index oligoclonal bands and malignant cells. Serum
anti Aquaporin-4 and anti-MOG antibodies were undetectable.

• Primary JCV infection occurs asymptomatically during childhood. The virus
replication remains suppressed by cellular immunity, it remains dormant
usually in the kidneys, lympho- reticular system, or brain tissue. Seventy to
ninety percent of adults are seropositive for the JC virus and the viral DNA is
detected in the urine of 20% to 30% of immunologically intact adults.
• Reactivation of dormant virus is seen most commonly in the setting of HIV
infection, hematologic malignancy, or with iatrogenic immunosuppression
due to failure of cellular immune surveillance to suppress viral replication.
• CSF is characterized by elevated protein levels but no pleocytosis. These
findings indicate that signs of universal or meningeal inflammation are not
suggestive of PML.
• PML lesions are typically multifocal at the grey white matter junction in the
brain, cerebellum, and brain stem that are contrast non enhancing.
• Mefloquine, a drug approved for malaria therapy, has recently shown to
influence the activity of JCV in a screening bioassay when it is applied on a
human glial cell line infected with JCV. Mirtazapine, an inhibitor of 5HT2Areceptor, which may be used by JCV for cell entry has been shown to inhibit
the infection of a human astroglia cell line.
• Primary PML disease should be differentiated from PML-immune
reconstitution inflammatory syndrome (PML-IRIS), which may develop in
patients with JCV CNS infection in the setting of recovery of the immune
system.

Case Report Cont.

EMG showed mildly prolonged distal sensory latencies, slight decrease in the
motor amplitudes and frequent fasciculations with no evidence of denervation
Magnetic resonance imaging (MRI) of the brain and spine showed nonenhancing T2 FLAIR hyper intense lesions involving the ponto-medullary
junction, and the spinal cord extending from T10 to the conus medullaris. The
patient was started on IV pulse steroids for 5 days, followed by a course of oral
prednisone of 60 mg daily. However, the weakness progressed to involve both
his upper extremities
Repeat MRI of the brain and spine showed severe progression of the T2/FLAIR
hyperintense lesions involving the posterior pons, medulla oblongata and entire
spinal cord. All parenchymal lesions were non-contrast enhancing. The conus
medullaris had a tumefactive appearance.
Repeated CSF analysis showed elevated protein of 93 positive JCV PCR.
Follow up EMG showed progression of the disease with evidence of wide spread
radiculopathy and anterior horn cell involvement. Prednisone was gradually
tapered off. Patient received a 5-day course of IVIG.
His condition continued to deteriorate with involvement of respiratory and
bulbar muscles. Patient condition continued to deteriorate with involvement of
respiratory and bulbar muscles and eventually family withdrew care.

• The lesions are contrast enhancement on neuroimaging due to severe
inflammation and demyelination with marked infiltration by macrophages
and CD8+ T lymphocytes.

Images 2: spinal cord T2 hyperintense lesions, all non-contrast enhancing

Conclusion
JC virus CNS infection is a rare but frequently fatal disease. It should be
suspected in immunosuppressed patients with rapid neurological decline.
Typically, it affects the brain and the cerebellum, however it should be included
in the differential diagnosis for LETM, particularly if the lesions are noncontrast enhancing. JCV PCR is sensitive and specific as a useful tool for
diagnosis. While no effective treatment has been identified reconstitution of the
immune state might suppress the viral replication. PML-IRIS is an autoimmune
condition that might result from hyper-immune reaction in the setting of immune
reconstitution and usually respond to high dose IV steroids or IVIG.
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A 62 years old male presented with rapidly progressing bilateral lower extremity
weakness and difficulty walking for less than a month.
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His medical history is significant for chronic lymphocytic leukemia and
chemotherapy induced hypogammaglobinemia that was managed with monthly
intravenous immunoglobulin and remained free of relapses until 2018.
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Image 1: T2 hyperintense lesion involving the posterior pons, medulla oblongata that
is non- contrast enhancing
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